GTx

About:

At GTx, They focus on the development of small molecules that selectively modulate the effects of certain hormones produced by the body.

Website: http://www.gtxinc.com

Twitter/X: capesaris

Top Investors: Biotechnology Value Fund, Boxer Capital, Abingworth, Aisling Capital, Amzak Capital Management

Description:

GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways.

Total Funding Amount:

$163M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Memphis, Tennessee, United States

Founded Date:

1997-01-01

Contact Email:

investor.relations(AT)gtxinc.com

Founders:

Andrew Romans, Mitchell Steiner

Number of Employees:

51-100

Last Funding Date:

2017-09-26

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai